Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-25,612
Closed -$209K – 3569
2025
Q3
$209K Buy
+25,612
New +$192K ﹤0.01% 2391
2023
Q3
– Sell
-147,845
Closed -$1.71M – 2724
2023
Q2
$1.71M Buy
+147,845
New +$1.74M 0.02% 679
2022
Q1
– Sell
-19,255
Closed -$654K – 3437
2021
Q4
$654K Buy
19,255
+1,027
+6% +$37.3K ﹤0.01% 1556
2021
Q3
$785K Buy
18,228
+3,643
+25% +$224K ﹤0.01% 1522
2021
Q2
$950K Buy
+14,585
New +$923K 0.01% 1174
2019
Q1
– Sell
-3,050
Closed -$378K – 657
2018
Q4
$378K Sell
3,050
-553
-15% -$91.1K 0.05% 281
2018
Q3
$879K Buy
+3,603
New +$833K 0.14% 123

Other funds holding INGN

HRT Financial's INGN Position: Q4 2025 in Review

HRT Financial sold out of Inogen (INGN) in Q4 2025, closing a stake of 25,612 shares — an estimated $209K sold.

HRT Financial first reported a position in INGN in Q3 2018 and held it in 7 quarters. The position peaked at $1.71M in Q2 2023. 133 funds tracked by Wall St. Rank hold INGN as of Q4 2025.

  • HRT Financial reported no remaining Inogen position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 25,612 Inogen shares in Q4 2025, an estimated $209K.
  • HRT Financial first reported a position in Inogen in Q3 2018 and held it in 7 quarters.
  • HRT Financial's Inogen position peaked at $1.71M in Q2 2023.
  • 133 funds tracked by Wall St. Rank held Inogen as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.